Sector portfolio · VC firm · Switzerland

Verve Ventures' Biotech portfolio

Verve Ventures has backed 13 Biotech startups in rounds we track, $306M between them, shown by the stage each has reached. The best-funded is Nuclera.

13startups backed
4stages
$306Mraised between them
Stage not reportedbiggest stage

Verve Ventures's whole portfolioVerve Ventures's profile

Stage not reported

6

Series C and later

3

Pre-seed and seed

2

Series B

2

Segment by segment

Stage not reported

6 startups · $80M raised

  1. FineHeartFineHeart is a medical device companyFrance$56M
  2. Nagi BioscienceNagi Bioscience aims to revolutionize the way toxic and/or beneficial effects of substances are tested.Switzerland$14M
  3. MedyriaMedyria is a Swiss medtech company founded in 2012 that specializes in sensor-based technologies for blood flow velocity (BFV) sensing.Switzerland$6.7M
  4. QQnamiSwitzerland$2.6M
  5. PEMREDPEMRED is a technological and scientific-based provider of exhaust after-treatment solutions.Switzerland$1.0M
  6. LimulaLimula offers a modular and automated solution for on-demand and at-scale manufacturing of cell therapies.Switzerland$566K

Series C and later

3 startups · $144M raised

  1. NucleraNuclera is a biotechnology company focused on making proteins more accessible to enhance drug discovery, proteomics, and life scieUnited Kingdom$95M
  2. Memo TherapeuticsMemo Therapeutics is an innovator in the field of antibody discovery and immune repertoire analysis.Switzerland$24M
  3. AbionicAbionic is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology.Switzerland$24M

Pre-seed and seed

2 startups · $39M raised

  1. BiograilBiograilTM is a pre-clinical stage pharmaceutical company leveraging its proprietary BIONDDTM technology to unlock the potential oDenmark$33M
  2. Kyron.biokyron.bio is a biotechnology company based in Paris, founded in 2022.France$6.2M

Series B

2 startups · $43M raised

  1. PathoQuestPathoQuest is a biotech company developing NGS-based metagenomic tests for exhaustive identification of pathogens.France$22M
  2. OncoDNAOncoDNA is a Belgium-based genomic and theranostic company focused on precision medicine for cancer and genetic diseases.Belgium$21M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Verve Ventures as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Sector portfolioVerve Ventures' AI portfolio12 startups · $413MPortfolio mapVerve Ventures portfolio map66 startups · $1.5BCo-investorsWho invests with Verve Ventures43 co-investorsSector portfolioNovartis' Biotech portfolio51 startups · $5.4BSector portfolioLakestar's AI portfolio26 startups · $4.6BSector portfolioLakestar's Fintech portfolio20 startups · $7.3B

Raising from investors like Verve Ventures?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps